Under these conditions, which may be represented by SkBr2 breast cancer cells, GPER/EGFR signaling could allow stimulatory effects by environmental estrogens, as shown in the present study and in previous studies (Maggiolini and Picard 2010; Pupo et al. 2012). Here, EGFR is linked to breast carcinoma.